Abstract
Bariatric surgery for morbid obesity is an effective approach to weight loss in selected obese patients. The candidate for surgery must be massively obese and have failed to lose appreciable weight with diet, drugs, and exercise. He must also be committed to lifelong weight maintenance. Bariatric surgical procedures either limit the expansion of the stomach (restrictive surgery) or the effective mixing of gastric contents with bile and pancreatic enzymes (bypass surgery). Gastric bypass is the most commonly performed bariatric procedure in the United States. Bariatric surgery-induced weight loss is associated with improvements in cardiovascular respiratory, and metabolic function. Two recent studies have shown significant survival benefit for people who have bariatric surgery (most had restrictive surgery). However, bariatric surgery is risky with an appreciable perioperative mortality. Although bypass surgery usually produces more weight loss than restrictive surgery, it is associated with more complications caused by malabsorption of nutrients such as fat, protein, and fat soluble vitamins.
Current Respiratory Medicine Reviews
Title: Bariatric Surgery and it Effects on the Respiratory System
Volume: 4 Issue: 2
Author(s): E. Paul Cherniack and Neil S. Cherniack
Affiliation:
Abstract: Bariatric surgery for morbid obesity is an effective approach to weight loss in selected obese patients. The candidate for surgery must be massively obese and have failed to lose appreciable weight with diet, drugs, and exercise. He must also be committed to lifelong weight maintenance. Bariatric surgical procedures either limit the expansion of the stomach (restrictive surgery) or the effective mixing of gastric contents with bile and pancreatic enzymes (bypass surgery). Gastric bypass is the most commonly performed bariatric procedure in the United States. Bariatric surgery-induced weight loss is associated with improvements in cardiovascular respiratory, and metabolic function. Two recent studies have shown significant survival benefit for people who have bariatric surgery (most had restrictive surgery). However, bariatric surgery is risky with an appreciable perioperative mortality. Although bypass surgery usually produces more weight loss than restrictive surgery, it is associated with more complications caused by malabsorption of nutrients such as fat, protein, and fat soluble vitamins.
Export Options
About this article
Cite this article as:
Cherniack Paul E. and Cherniack S. Neil, Bariatric Surgery and it Effects on the Respiratory System, Current Respiratory Medicine Reviews 2008; 4 (2) . https://dx.doi.org/10.2174/157339808784222768
DOI https://dx.doi.org/10.2174/157339808784222768 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mitochondrial Complex I Deficiency in Humans
Current Genomics Biochemical Markers of Cardiovascular Damage from Tobacco Smoke
Current Pharmaceutical Design Editorial (Thematic Issue: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Dev elopment (Part C))
Current Pharmaceutical Design Cardiotoxicity of Molecularly Targeted Agents
Current Cardiology Reviews Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Antagonists in Experimental Myocarditis
Current Pharmaceutical Design Aldose Reductase Inhibition: Emerging Drug Target for the Treatment of Cardiovascular Complications
Recent Patents on Cardiovascular Drug Discovery A Review of the Cardiovascular and Anti-Atherogenic Effects of Ghrelin
Current Pharmaceutical Design Prevention of Ischemic Stroke: Antithrombotic Therapy in Cardiac Embolism
Current Drug Targets QT Alterations in Psychopharmacology: Proven Candidates and Suspects
Current Drug Safety Sacubitril/Valsartan: A New Dawn has Begun! A Revisited Review
Current Cardiology Reviews microRNA Regulation as a Therapeutic Strategy for Cardiovascular Disease
Current Drug Targets Human Immunodeficiency Virus (HIV) and Stroke: Targets for Intervention
Infectious Disorders - Drug Targets Mitochondrial Injury and Targeted Intervention in Septic Cardiomyopathy
Current Pharmaceutical Design Diabetes, the Renin-Angiotensin System and Heart Disease
Current Vascular Pharmacology Current Advances in the Synthesis and Antitumoral Activity of SIRT1-2 Inhibitors by Modulation of p53 and Pro-Apoptotic Proteins
Current Medicinal Chemistry Evaluation of Echocardiographic Abnormalities in HIV Positive Patients Treated with Antiretroviral Medications
Infectious Disorders - Drug Targets High Sensitivity Troponin in Cardiovascular Disease. Is There More Than a Marker of Myocardial Death?
Current Topics in Medicinal Chemistry Biomarkers of Protein Oxidation in Human Disease
Current Molecular Medicine The Role of Chymase in Vascular Remodeling and Tissue Fibrosis
Current Hypertension Reviews Morphological and Molecular Changes of the Myocardium After Left Ventricular Mechanical Support
Current Cardiology Reviews